Project Details
Description
A Follow-Up, Open-Label, Research Evaluation of Sustained Treatment with Aficamten (CK-3773274) in Hypertrophic Cardiomyopathy (HCM)
| Status | Active |
|---|---|
| Effective start/end date | 11/13/25 → 10/30/35 |
Funding
- CYTOKINETICS, INCORPORATED
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.